Jens Ceder

affiliated with the universityFormer name: Jens Hansson
More filtering options
  1. 2017
  2. Targeting prostate cancer stem cells with alpha-particle therapy

    Elgqvist, J. & Jens Ceder, 2017 Jan 9, In : Frontiers in Oncology. 6, 11 p., 273.

    Research output: Contribution to journalArticle

  3. 2015
  4. Targeting the Mechanisms of Progression in Castration-resistant Prostate Cancer.

    Jens Ceder, 2015, In : European Urology. 67, 3, p. 480-481

    Research output: Contribution to journalDebate/Note/Editorial

  5. 2014
  6. REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.

    Svensson, C., Jens Ceder, Iglesias-Gato, D., Chuan, Y-C., Pang, S. T., Anders Bjartell, Martinez, R. M., Bott, L., Helczynski, L., David Ulmert, Wang, Y., Niu, Y., Collins, C. & Flores-Morales, A., 2014, In : Nucleic Acids Research. 42, 2, p. 999-1015

    Research output: Contribution to journalArticle

  7. 2013
  8. miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.

    Hagman, Z., Haflidadottir, B., Jens Ceder, Larne, O., Anders Bjartell, Hans Lilja, Edsjö, A. & Yvonne Ceder, 2013, In : British Journal of Cancer. 108, 8, p. 1668-1676

    Research output: Contribution to journalArticle

  9. 2010
  10. Identification of urothelial stem cells for tissue engineering

    Sun, W., Jens Ceder, Geutjes, P. J., Schalken, J. A. & Oosterwijk, E., 2010, In : Differentiation. 80, p. S46-S46

    Research output: Contribution to journalPublished meeting abstract

  11. Label retaining cells and stem cell marker expression in the developing and adult mouse prostate

    Jens Ceder, Aalders, T., Jansen, K., Abrahamsson, P-A. & Schalken, J. A., 2010, In : Differentiation. 80, p. S39-S39

    Research output: Contribution to journalPublished meeting abstract

  12. 2009
  13. SOMATOSTATIN IS EXPRESSED IN THE HUMAN PROSTATE STEM CELL NICHE AND INHIBITS EXPANSION OF LUMINAL PRECURSOR CELLS

    Jens Ceder, Jansson, L., Kjellstrom, K. & Abrahamsson, P-A., 2009, In : European Urology Supplements. 8, 4, p. 248-248

    Research output: Contribution to journalPublished meeting abstract

  14. 2008
  15. Regulatory Proteins in Progenitors and Differentiated Cells of the Human Prostate

    Jens Ceder, 2008, Department of Clinical Sciences, Lund University. 113 p.

    Research output: ThesisDoctoral Thesis (compilation)

  16. The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate.

    Jens Ceder, Linda Jansson, Ehrnström, R., Lars Rönnstrand & Abrahamsson, P-A., 2008, In : European Urology. 53, 3, p. 524-532

    Research output: Contribution to journalArticle

  17. The Identification of a Novel Stromal Stem/Progenitor Cell Phenotype in the Human Adult Prostate

    Jens Ceder, Linda Jansson, Ehrnström, R., Lars Rönnstrand & Abrahamsson, P-A., 2008, In : European Urology Supplements. 7, 3, p. 93

    Research output: Contribution to journalPublished meeting abstract

  18. 2005
  19. Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.

    Anders Bjartell, Paju, A., Zhang, W-M., Gadaleanu, V., Jens Ceder, Landberg, G. & Stenman, U-H., 2005, In : The Prostate. 64, 1, p. 29-39

    Research output: Contribution to journalArticle

  20. Role of somatostatin receptors in prostate carcinoma

    Jens Ceder, 2005, Handbook of immunohistochemistry and in situ hybridization of human carcinomas. Hayat, M. A. (ed.). Elsevier, Vol. 2. p. 387

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  21. 2004
  22. Behandlingsmodell med Somatostatinanaloger vid Hor

    Jens Ceder, 2004, Cancerforskning i Region Skåne och Södra Sjukvårdsregionen. Wiberg, I. (ed.). Forsknings- och utvecklingsenheten, Vol. 2. p. 62

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  23. 2003
  24. Neuroendocrine differentiation in prostatic carcinoma.

    Jens Ceder & Abrahamsson, P-A., 2003, In : Scandinavian Journal of Urology and Nephrology, Supplementum. Suppl 212, p. 28-36

    Research output: Contribution to journalArticle

  25. 2002
  26. Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.

    Jens Ceder, Anders Bjartell, Gadaleanu, V., Dizeyi, N. & Abrahamsson, P-A., 2002, In : The Prostate. 53, 1, p. 50-59

    Research output: Contribution to journalArticle

  27. Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.

    Dizeyi, N., Konrad, L., Anders Bjartell, Wu, H., Gadaleanu, V., Jens Ceder, Helboe, L. & Abrahamsson, P-A., 2002, In : Urologic Oncology. 7, 3, p. 91-98

    Research output: Contribution to journalArticle

  28. Neuroendocrine Mediators in Prostate Cancer Progression

    Abrahamsson, P-A. & Jens Ceder, 2002, Expanding Role of Octreotide I: Advances in Oncology. Lamberts, SW. & Dogliotti, L. (eds.). BioScientifica Ltd., p. 279

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  29. 2001
  30. Neuroendocrine pathogenesis in adenocarcinoma of the prostate

    Jens Ceder & Abrahamsson, P-A., 2001, In : Annals of Oncology. 12, Suppl. 2, p. S145-S152

    Research output: Contribution to journalArticle

  31. 2000
  32. Expression and characterization of trypsinogen produced in the human male genital tract

    Paju, A., Anders Bjartell, Zhang, W. M., Nordling, S., Borgström, A., Jens Ceder & Stenman, U. H., 2000, In : American Journal of Pathology. 157, 6, p. 2011-2021

    Research output: Contribution to journalArticle